Global Acetaminophen API Market Expected to Reach USD 1,648.2 Million by 2033

The global acetaminophen API market is poised for significant growth, projected to surpass USD 1,180.4 million in 2023 and estimated to achieve a valuation of USD 1,648.2 million by 2033. According to recent market analysis, the acetaminophen API industry is expected to thrive at a Compound Annual Growth Rate (CAGR) of 3.4% from 2023 to 2033.

Acetaminophen, a widely-used over-the-counter and prescription medication for pain relief and fever reduction, continues to witness increasing demand globally. Factors contributing to this surge include the aging population, expansion of healthcare systems, and growing healthcare expenditures in various countries.

Get Access to Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-12465

Chronic illnesses such as arthritis, back pain, and headaches are on the rise worldwide, further bolstering the demand for acetaminophen API. As a first-line therapy for these conditions, acetaminophen finds extensive use in pharmacological formulations, including cold and flu medications.

The pharmaceutical industry’s rapid expansion, coupled with geographic and manufacturing capacity growth among pharmaceutical firms, has contributed significantly to the increased demand for acetaminophen API.

Moreover, favorable governmental regulations concerning medication safety, efficacy, and accessibility play a pivotal role in propelling the growth of the acetaminophen API industry. These regulations create a conducive environment for market expansion, facilitating the inclusion of acetaminophen in various therapeutic formulations.

North America is anticipated to dominate the acetaminophen API market during the forecast period. Factors such as escalating healthcare expenditure and the widespread availability of affordable healthcare solutions in the region are driving market growth. Additionally, the rising incidence of cardiovascular diseases further fuels the demand for effective analgesics, contributing to market expansion.

As the global acetaminophen API market continues to evolve, stakeholders across the pharmaceutical sector are poised to capitalize on emerging opportunities and navigate dynamic market trends effectively.

Key Takeaways from Acetaminophen API industry Report:

• In 2018, the global market size stood at USD 1,039.1 million.
• The market expanded at a CAGR of 2.1% from 2018 to 2022.
• In 2022, the global market size stood at USD 1,150.2 million.
• North America captured 33.4% of global market shares in 2022.
• China captured 4.6% of global market shares in 2022.
• Japan captured 5.2% of global market shares in 2022.
• The United Kingdom captured 3.8 global market shares in 2022.
• The pharmaceutical industry segment under end-user captured 38.60% of global market shares in 2022.
• The acetaminophen injection segment acquired 31.40% of global market shares in 2022.

Get Customization on This Report: https://www.futuremarketinsights.com/customization-available/rep-gb-12465

Recent Developments Observed by FMI:

• Genexa unveiled the first-ever clean adult acetaminophen painkiller products in May 2022. The active components and dosages of Genexas Acetaminophen Extra Strength and Acetaminophen PM caplets are the same as those of the market leaders despite the absence of artificial colors, synthetic fillers, and other artificial preservatives.
• In April 2023, Haleon, a multinational consumer healthcare firm, launched its first analgesic from organic ingredients thanks to WhiteGrey’s marketing. PanaNatra is the first item in a new ‘naturals’ subcategory from the producers of Panadol, and it debuted with the marketing slogan ‘Who Said Natural Hasn’t Got What It Takes?

Key Players in the Global Market:

• BOC Sciences
• Tianjin Bofa Acetaminophen
• Mallinckrodt plc
• Kemcolour International
• Chnagshu Huagang Acetaminophen
• Haohua Industry
• Kangle Acetaminophen
• Angene International Limited
• Anhui BBCA Acetaminophen
• Granules India
• Hebei Jihgeng Acetaminophen

A Comprehensive Full Report: https://www.futuremarketinsights.com/checkout/12465

Acetaminophen API industry Segmentation:

By Type:

• Veterinary Drug Grade Acetaminophen API
• Acetaminophen Grade Acetaminophen API

By End User:

• Pharmaceutical Industry
• Research Labs
• Educational Institutes
• Others

By Product Form:

• Acetaminophen Tablets (Film-coated, Extended-release)
• Oral Acetaminophen
• Acetaminophen Suppository
• Acetaminophen Injection
• Others

By Indications:

• Antipyretic Acetaminophen APIs
• Acetaminophen Analgesics

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube